MOESM1 of Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis

Additional file 1: Table S1. Antibodies for immunofluorescent, Western blotting, and immunohistochemical staining.